Peptide Policy Watch
Peptides in plain English: wellness, evidence and the rules
Heard “peptides” at the gym, on a skincare label or in a group chat, and wondered what’s real? We explain what they are, what the research does and doesn’t show, what the FDA has actually approved, and what to ask your clinician. Every post links its sources and says so when we couldn’t confirm something. Explanation only, never medical advice.
Original illustration generated for this site (AI-generated). Image credits
Start here
Five doors in, depending on what brought you. Each one is a short, sourced explainer.
New to the word?
Peptides, in plain English: what they are, and why one word covers so much
One word covers a prescription medicine and a gym-chat compound. Start with what it actually means.
Who decides what?
Where peptide regulation stands right now: a plain-English timeline
A dated timeline of what FDA has said, and what it has not.
Enter races or lifting meets?
Which popular gym peptides are banned in sport? What WADA's 2026 and 2027 lists name
See which gym-circle peptides the anti-doping lists name, and what a supplement label does not change.
Heard "there's research on it"?
Everyone in the gym is talking about peptides. Here's what the research actually says
Cells, animals or people? Learn which rung of the ladder a claim stands on.
This week
This week in peptide policy: October 19–25, 2026
What moved, and what stayed put, in our latest weekly check.
What we try to do
Short, friendly explainers for curious readers: the wellness questions people really ask, the evidence behind them, and the rules that shape what’s legal and what’s approved.
- Plain English firstNo jargon walls. Short paragraphs and clear headings.
- Evidence, labeledWe say whether a claim rests on human studies, animal or cell work, or just talk.
- Rules as one lensWhat FDA-approved means, and what it does not, for a shopper.
- Questions, not adviceMost posts end with better questions to bring to a clinician.
Latest and most useful
- Wellness
- Evidence
- FDA
Peptides, in plain English: what they are, and why one word covers so much
What peptides are, how FDA draws the line between a peptide and a protein, and why the same word covers approved medicines and wellness-market products.
- Wellness
- FDA
- Compounding
"It's a peptide": three very different things hiding behind one word
Approved peptide medicines, compounded drugs and wellness-market peptides side by side: what FDA reviewed, what a label tells you, and what it does not.
- Wellness
- FDA
- Policy
From insulin to Ozempic: a timeline of how peptide medicines went from niche to mainstream
A dated timeline of how peptide medicines went from insulin to GLP-1 drugs, and how that changed the money, the FDA rules and public interest.
- Safety and quality
- Compounding
- Wellness
The glutathione injection recall: what FDA's October 1 notice says, and what it doesn't
FDA's Oct 1, 2026 notice on a compounded glutathione injection recall for possible endotoxin: what it says, what CDC and FDA add, what's unconfirmed.
- Compounding
- Advisory committee
- Wellness
GHK-Cu is in skincare and on FDA's compounding list. Here's what "except injectable" means
GHK-Cu, the copper peptide in skincare, is on FDA's Category 1 compounding list except for injectables, with an advisory meeting due by February 2027.
- Evidence
- Fitness and recovery
- Wellness
Everyone in the gym is talking about peptides. Here's what the research actually says
A plain-English evidence ladder, from cells to animals to people, applied to BPC-157: one 2025 review counted 1 human study, a 2026 review counts 3.
- Fitness and recovery
- Safety and quality
- Wellness
Which popular gym peptides are banned in sport? What WADA's 2026 and 2027 lists name
Which peptides do WADA's 2026 and 2027 Prohibited Lists name, what strict liability means for supplements, and what WADA says about GLP-1 drugs.
- FDA
- Advisory committee
- Policy
Where peptide regulation stands right now: a plain-English timeline
A plain-English timeline of peptide regulation as of October 25, 2026: what FDA documents show, what is only reported, and what is still pending.
- Policy
- FDA
This week in peptide policy: October 19–25, 2026
A quiet week for official peptide and compounding actions, October 19-25, 2026, with the reported HHS interim policy still under White House review.
- Telehealth
- Legal
- FDA
Hims & Hers, the FTC and the FDA: who has actually said what about telehealth and compounded drugs
What the FTC and FDA have each said about telehealth companies and compounded drugs, from public documents, and what each does not cover.
- Compounding
- FDA
- Safety and quality
What FDA's "Category 1" and "Category 2" actually mean (and what they don't)
What FDA's Category 1 and Category 2 labels for compounded bulk substances mean, and what they do not mean, using FDA's own documents.
Browse by topic
- WellnessPeptides in self-care, plain and simple: what people are asking and what the sources say.7 posts
- Fitness and recoveryGym talk, recovery claims and sport rules, checked against the evidence.2 posts
- EvidenceWhat kind of proof sits behind a claim: cell, animal, human trial or anecdote.3 posts
- Safety and qualityLabels, quality checks, warning letters and the red flags worth knowing.5 posts
- FDAWhat the FDA has said, listed or proposed: statements, category lists, notices and warning letters.8 posts
- TelehealthHow telehealth companies and the agencies that watch them show up in public documents.1 post
- LegalCourt cases, complaints and legal terms, explained without legal advice.1 post
- Clinical trialsTrial registry entries and results, reported as published.No posts yet
- CompoundingHow compounding rules and FDA's bulk-substance categories work.4 posts
- Advisory committeeFDA advisory committee meetings, agendas, and what their votes do and don't mean.2 posts
- PolicyGovernment policy moves that are still pending or under review.3 posts
How this site works
- Primary sources, dated. Every claim links to an official document or says it is reported by someone else. How we source.
- Reporting, not advice. We do not publish dosing, protocols or where to buy anything. The site owner is not a medical professional. Disclaimer.
- Independent. No sponsors and no affiliate links at this time. Affiliate disclosure.
- Who writes this. An independent individual publisher using AI-assisted drafting and a written checklist. Editorial team and editorial standards.
- Spot a mistake? Tell us and we will fix it and say so.